Literature DB >> 6973618

Emergence of rifampin-resistant Haemophilus influenzae after prophylaxis.

T V Murphy, G H McCracken, T C Zweighaft, E J Hansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6973618     DOI： 10.1016/s0022-3476(81)80328-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  11 in total

1.  Rifampicin prophylaxis for throat carriage of Haemophilus influenzae type b in patients with invasive disease and their contacts.

Authors:  G L Gilbert; S J MacInnes; I A Guise
Journal:  BMJ       Date:  1991-06-15

2.  Chemoprophylaxis for the prevention of bacterial meningitis.

Authors:  U B Schaad
Journal:  Infection       Date:  1984       Impact factor: 3.553

3.  Rifampicin in non-tuberculous infections.

Authors:  A J Davies; D A Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-07

4.  Mutation frequency of Haemophilus influenzae to rifampin resistance.

Authors:  P M Mendelman; M C Roberts; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

5.  Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.

Authors:  M M París; S Shelton; M Trujillo; S M Hickey; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

6.  Rifampin resistance of Legionella pneumophila is not increased during therapy for experimental Legionnaires disease: study of rifampin resistance using a guinea pig model of Legionnaires disease.

Authors:  P H Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

7.  Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis.

Authors:  G R Siber; D M Ambrosino; J McIver; T J Ervin; G Schiffman; S Sallan; G F Grady
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

8.  Rifampin alone or with trimethoprim for contacts of children with Haemophilus influenzae type b infections.

Authors:  T Jadavji; R Cheung; R M Bannatyne; C G Prober
Journal:  CMAJ       Date:  1986-08-15       Impact factor: 8.262

9.  Emergence of rifampin-resistant Haemophilus influenzae.

Authors:  L E Nicolle; B Postl; E Kotelewetz; W Albritton; G K Harding; A M Bourgault; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

10.  In vitro development of rifampin resistance in clinical isolates of Haemophilus influenzae type b.

Authors:  R Yogev; C Melick; W Glogowski
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.